Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
21.01.23
-
24.05.24
-
26.01.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Hutchison China MediTech Ltd ADR

Start price
Target price
Perf. (%)
€15.50
19.01.23
-
19.01.24
-21.29%
20.01.24

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.78
13.01.23
€17.00
31.05.24
-9.18%
05.05.23

Could be very worthwhile Investment >20% year
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€15.65
03.01.23
€22.00
31.12.25
23.98%
05.05.23

Could be very worthwhile Investment >20% year
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.00
03.01.23
€70.00
31.12.25
-10.09%
05.05.23

Could be very worthwhile Investment >20% year
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€315.50
02.01.23
€444.00
02.01.24
5.23%
07.01.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Novocure Ltd

Start price
Target price
Perf. (%)
€68.89
02.01.23
€30.00
31.12.25
71.43%
05.01.23

Could be very worthwhile Investment >20% year
Opko Health Inc.

Start price
Target price
Perf. (%)
€1.14
27.12.22
-
27.12.23
11.81%
24.04.23

Risky Investment
buy
Orion Corp. B

Start price
Target price
Perf. (%)
€53.78
22.12.22
-
22.12.23
-34.90%
24.08.23

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.20
07.12.22
-
07.12.23
-16.53%
10.12.22

Risky Investment
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€72.50
02.12.22
-
02.12.23
22.69%
03.12.23

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.58
21.11.22
-
21.11.23
-85.09%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.63
19.11.22
€2.50
19.11.23
-46.91%
11.03.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Sartorius AG VZO

Start price
Target price
Perf. (%)
€396.90
15.11.22
-
15.11.23
-30.86%
16.11.23

buy
Evotec SE

Start price
Target price
Perf. (%)
€19.00
12.11.22
€25.00
12.11.23
-7.37%
12.11.23

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Some uniques
buy
Syneos Health, Inc.

Start price
Target price
Perf. (%)
€26.12
04.11.22
-
04.11.23
23.91%
10.11.22

Risky Investment
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€7.95
28.10.22
-
28.10.23
-16.20%
29.10.22

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€9.52
26.10.22
-
26.10.23
-30.01%
30.10.22

Could be very worthwhile Investment >20% year
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€218.90
25.10.22
€190.00
25.10.23
11.47%
26.10.23

Could be worthwhile Investment >10% per year
Viatris Inc.

Start price
Target price
Perf. (%)
€9.76
18.10.22
-
18.11.26
13.97%
11.03.24

Probably not worthwhile Investment
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.44
17.10.22
-
17.10.23
-7.41%
22.12.22

Risky Investment
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.14
16.10.22
-
16.10.23
-3.57%
18.02.23

Risky Investment
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.55
13.10.22
€2.30
13.10.23
42.55%
19.11.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.47
27.09.22
-
27.09.23
-13.02%
15.10.22

Risky Investment